Crescent Point Energy Corporation

Crescent Point Energy Corporation (NYSE: CPG) is a Canada-based oil and gas exploration company focused on the development of oil resource plays based in Calgary, Alberta. Noted below are the key price indicators for the stock: 

Technical Observation (on the Weekly Chart)

CPG’s prices are facing stiff resistance from the USD 8.00 level on the higher side and consolidating around this level for the past couple of weeks, indicating a possibility of a downside correction in the stock prices. However, the leading indicator RSI (14-period) is showing a reading of 62.18 and prices are above the trend-following indicator 21-period SMA and 50-period SMA, supporting an up-move.  

Conclusion

As per the above-mentioned price action and technical indicators analysis, we have a ‘Watch’ rating on Crescent Point Energy Corporation at the close price of USD 7.67 (as of May 17, 2022). Investors can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a biopharmaceutical company engaged in discovering and developing small molecule therapeutics. Noted below are the key price indicators for the stock:

Technical Observation (on the Weekly Chart)

KYMR has broken a crucial support level of USD 25.43 on May 03, 2022, and since then has been trading below the breakout level. The leading indicator RSI (14-period) is still consolidating in an oversold zone and prices are trading below the trend-following indicator 21-period SMA and 50-period SMA, supporting further downside direction.

Conclusion

As per the above-mentioned price action and technical indicators analysis, we have a ‘Watch’ rating on Kymera Therapeutics, Inc. at the close price of USD 17.43 (as of May 17, 2022). Investors can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Motus GI Holdings, Inc.

Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company engaged in providing endoscopy solutions through its subsidiaries in the United States and Israel. Noted below are the key price indicators for the stock:

Technical Observation (on the Weekly Chart)

MOTS' prices are forming lower lows and lower highs formation on the chart, indicating an overall downtrend for the stock. The leading indicator RSI (14-period) is still consolidating around an oversold zone and prices are trading below the trend-following indicator 21-period SMA and 50-period SMA, supporting further downside direction. 

Conclusion

As per the above-mentioned price action and technical indicators analysis, we have a ‘Watch’ rating on Motus GI Holdings, Inc. at the close price of USD 0.2561 (as of May 17, 2022). Investors can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.

Note 1: Investment Related Risks: This report may be looked at by Investors with sufficient risk appetite looking for returns within a short investment duration. Investment recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

Note 2: How to Read the Charts?

The Green colour line reflects the 21-period moving average while the red line indicates the 50- period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.

The Black colour line in the chart’s lower segment reflects the Relative Strength Index (14-Period) which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status while a reading of 30 or below suggests an oversold status.

The Blue colour bars in the chart’s lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume as liquidity in stocks helps in easier and faster execution of the order.

The Orange colour lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.

Technical Indicators Defined: -

Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

The reference date for all price data, volumes, technical indicators, support, and resistance levels is May 17, 2022. The reference data in this report has been partly sourced from REFINITIV. 

Abbreviations

CMP: Current Market Price

SMA: Simple Moving Average

RSI: Relative Strength Index

USD: United States dollar 

Note: Trading decisions require a thorough analysis by investors. Technical reports in general chart out metrics that may be assessed by investors before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.